Tickers

1. Composite Trajectory Verdict

Given XOM's capital-intensive integrated energy business model, all three financial statements carry roughly equal weight: the income statement reflects commodity-driven earnings power, the cash flow statement captures the ability to fund high capex and shareholder returns, and the balance sheet shows resilience to price cycles and funding capacity.

Composite Trajectory: Deteriorating

All three statement-level assessments point to deterioration. Net income attributable to ExxonMobil has fallen for two consecutive years, from $36.0B in 2023 to $33.7B in 2024 to $28.8B in 2025 (10-K 2025-12-31, Consolidated Statements of Operations). Operating cash flow has declined each year, from $55.4B in 2023 to $55.0B in 2024 to $52.0B in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The balance sheet shows cash and cash equivalents more than halved over two years, from $31.6B at end-2023 to $10.7B at end-2025, while net debt nearly doubled from $18.5B to $32.9B and net debt to capital rose from 4.5% to 11.0% (10-K 2025-12-31, Consolidated Balance Sheets; MD&A Liquidity and Capital Resources). No statement shows an improving trend over the comparable annual periods provided.

2. Red Flags

• Consecutive annual declines in net income: Net income attributable to ExxonMobil fell 6.5% year-over-year in 2024 ($33.7B vs $36.0B) and a further 14.4% in 2025 ($28.8B vs $33.7B) (10-K 2025-12-31, Consolidated Statements of Operations).
• Operating cash flow declining while capital intensity rises: Operating cash flow dropped 5.5% in 2025 to $52.0B, while capex (additions to PP&E) rose 16.7% to $28.4B, widening the gap between internal cash generation and investment needs (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Liquidity and Capital Resources).
• Cash balance halved in two years: Cash and cash equivalents fell from $31.6B at end-2023 to $23.2B at end-2024 to $10.7B at end-2025, a 66% cumulative decline (10-K 2025-12-31, Consolidated Balance Sheets).
• Net debt nearly doubled in two years: Net debt (total debt less cash) increased from $18.5B at end-2024 to $32.9B at end-2025, with net debt to capital rising from 6.5% to 11.0% (10-K 2025-12-31, MD&A Liquidity and Capital Resources).
• Shareholder distributions exceed operating cash flow after capex: In 2025, dividends ($17.2B) plus share repurchases ($20.3B) totaled $37.5B, while operating cash flow after capex ($52.0B - $28.4B) was $23.6B, implying reliance on cash drawdown and debt (10-K 2025-12-31, MD&A Liquidity and Capital Resources).
• Corporate and Financing expenses surged: Corporate and Financing GAAP loss widened to $3.6B in 2025 from $1.4B in 2024, driven by higher financing costs (10-K 2025-12-31, MD&A Corporate and Financing).
• Chemical Products earnings collapsed: Segment earnings fell to $0.8B in 2025 from $2.6B in 2024 and $1.6B in 2023, with margins described as "deeply bottom-of-cycle" (10-K 2025-12-31, MD&A Chemical Products Financial Results).
• Upstream identified items swung to loss: Upstream identified items moved from a $215M gain in 2024 to an $893M loss in 2025, primarily due to asset impairments (10-K 2025-12-31, MD&A Upstream Financial Results).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Consolidated revenues declined 5.0% in 2025 to $332.2B after a modest 1.4% increase in 2024 (10-K 2025-12-31, Consolidated Statements of Operations). Net income attributable to ExxonMobil has fallen for two consecutive years: $36.0B (2023) → $33.7B (2024) → $28.8B (2025), a cumulative 20% decline (10-K 2025-12-31, Consolidated Statements of Operations). Earnings per share followed the same path: $8.89 → $7.84 → $6.70 (10-K 2025-12-31, Consolidated Statements of Operations). Segment performance was mixed but net negative: Upstream earnings dropped 15.9% to $21.4B in 2025; Energy Products recovered to $7.4B from $4.0B but remained well below the $12.1B peak in 2023; Chemical Products earnings collapsed 69% to $0.8B; Specialty Products eased slightly to $2.9B; Corporate and Financing loss widened to $3.6B from $1.4B (10-K 2025-12-31, MD&A segment financial results tables). The effective tax rate dipped to 31% in 2025 from 33% in 2023-24, providing a modest offset (10-K 2025-12-31, MD&A Taxes).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Net cash provided by operating activities has declined in each of the last two years: $55.4B (2023) → $55.0B (2024) → $52.0B (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). The 2025 decline of $3.1B was driven by a $5.3B drop in net income including noncontrolling interests, partially offset by a $2.6B increase in depreciation and depletion (10-K 2025-12-31, MD&A Cash Flow from Operating Activities). Investing cash outflows increased sharply to $25.9B in 2025 from $19.9B in 2024, primarily due to a $4.1B rise in PP&E spending to $28.4B (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A Cash Flow from Investing Activities). Financing cash outflows remained high at $39.1B in 2025, funding dividends ($17.2B) and share repurchases ($20.3B) (10-K 2025-12-31, MD&A Cash Flow from Financing Activities). The net result was a $12.5B decrease in cash and cash equivalents in 2025, following an $8.4B decrease in 2024, leaving the cash balance at $10.7B (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Overall Assessment: Total assets edged down 1.0% to $449.0B at end-2025 from $453.5B at end-2024 (10-K 2025-12-31, Consolidated Balance Sheets). Cash and cash equivalents fell 54% to $10.7B from $23.2B (10-K 2025-12-31, Consolidated Balance Sheets). Total debt (notes and loans payable plus long-term debt) rose to $43.5B from $41.7B, with short-term debt nearly doubling to $9.3B from $5.0B (10-K 2025-12-31, Consolidated Balance Sheets). Net debt (total debt less cash) therefore jumped to $32.9B from $18.5B (10-K 2025-12-31, MD&A Liquidity and Capital Resources). Total equity declined to $266.6B from $270.6B, as share repurchases ($20.3B) and dividends ($17.2B) exceeded net income (10-K 2025-12-31, Consolidated Balance Sheets; MD&A Cash Flow from Financing Activities). Debt to capital increased to 14.0% from 13.4%, and net debt to capital rose to 11.0% from 6.5% (10-K 2025-12-31, MD&A Financial Strength). The percentage of proved developed reserves remained at 64% of total proved reserves (10-K 2025-12-31, MD&A Liquidity and Capital Resources).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet data for 2026 (Q1 and Q2) and 2025 (Q1-Q3) to assess intra-year trends and compute same-quarter YoY comparisons; the provided 10-Q filings' detailed financial statements are not included in the supplied text.
• Segment-level cash flow statements (operating, investing, financing) to evaluate cash generation by business line.
• Detailed breakdown of "Other" line items in earnings driver analyses (e.g., Upstream "Other" +$0.6B, Energy Products "Other" +$0.2B) to assess recurrence.
• Full derivative fair value disclosures and hedge accounting details to evaluate mark-to-market volatility impact.
• Pension asset/liability funding status and expected contributions beyond the $150M sensitivity disclosed.
• Environmental liability rollforward beyond the $0.9B balance sheet figure and $0.4B provision in 2025.
• Detailed debt maturity profile beyond the 2026-2027 take-or-pay obligations ($6.3B and $6.2B) to assess near-term refinancing risk.